Digitwin.bio is the vertically-integrated predictive model for the dawning longevity medicine economy. DigiTwin enables predictive actionable navigation of the healthspan using a multi-scale digital t ...

DealForma maintains the most comprehensive database for biopharma deal benchmarking in a modern platform that combines highly curated licensing, venture, and M&A data, an intuitive interface, and biop ...

Daewoong Group's dedicated Strategic Investment CVC. Established as an external R&D sourcing vehicle to achieve the Group's 'Total Healthcare Group' vision. Provides portfolio companies with strategic ...

Deloitte is attending BIO 2025 on behalf of Australian Unity, a leading mutual company and developer of social infrastructure, to identify a Partner for a unique site at the heart of an established he ...

Digitalis is a venture capital firm that invests in solutions to complex problems in human and animal health.

Through exclusive licenses from J. Doudna (UCal) and C.Castro (OSU), DNA Nanobots folds target genes to be their own gene delivery vector. We are developing a portfolio of non-viral, DNA-based genobot ...

Dyadic (NASDAQ: DYAI) is a global biotech company utilizing its innovative microbial production platforms to meet growing global demand for effective and affordable biopharmaceutical products and alte ...

Duo Oncology is an oncology company reimagining chemotherapy, a foundational treatment for metastatic cancer. Its lead program, DUO-207, consolidates multi-drug chemotherapy regimens into a single, po ...